Home >> Current Pharmaceutical Design, Volume 10, Number 18
Current Pharmaceutical Design logo Bentham Science Publishers logo

Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Publisher: Bentham Science Publishers

Related content
Volume 10, Number 18, July 2004

< previous issue | all issues | next issue >

Book review

Preface [Hot Topic: Current Status of Neuroprotection in Traumatic Brain Injury (Executive Editors: Maria Mataro and Juan Sahuquillo)]
pp. i-i(1)
Authors: Mataro, Maria; Sahuquillo, Juan

Preface [Hot Topic: Multifaceted Treatment of Schizophrenia (Executive Editor: J. Ananth)]
pp. ii-iii(2)
Author: Ananth, Jambur

Review article

Molecular and Cellular Mechanisms in the Pathophysiology of Severe Head Injury
pp. 2131-2143(13)
Authors: P, Enriquez; R., Bullock

Microdialysis in Neurointensive Care
pp. 2145-2152(8)
Authors: Ungerstedt, Urban; Rostami, Elham

Importance of Aquaporins in the Physiopathology of Brain Edema
pp. 2153-2161(9)
Authors: Venero, Jose L.; Machado, Alberto; Cano, Josefina

Arterial Hyperoxia in Severe Head Injury: A Useful or Harmful Option?
pp. 2163-2176(14)
Authors: Alves, O. L.; Daugherty, W. P.; Rios, M.

Cannabinoids as Neuroprotective Agents in Traumatic Brain Injury
pp. 2177-2183(7)
Author: Biegon, Anat

Endothelins and the Role of Endothelin Antagonists in the Management of Posttraumatic Vasospasm
pp. 2185-2192(8)
Author: Armstead, W. M.

Moderate Hypothermia in the Management of Severe Traumatic Brain Injury: A Good Idea Proved Ineffective?
pp. 2193-2204(12)
Authors: Sahuquillo, J.; Mena, M. P.; Vilalta, A.; Poca, M. A.

Drug Therapy in Schizophrenia
pp. 2205-2217(13)
Authors: Ananth, J.; Parameswaran, S.; Hara, B.

Side Effects of Atypical Antipsychotic Drugs
pp. 2219-2229(11)
Authors: Ananth, J.; Parameswaran, S.; Gunatilake, S.

Antipsychotic Polypharmacy
pp. 2231-2238(8)
Authors: Ananth, J.; Parameswaran, S.; Gunatilake,

The Use of Antiparkinsonian Agents in the Management of Drug-Induced Extrapyramidal Symptoms
pp. 2239-2248(10)
Authors: Burgyone, K.; Aduri, K.; Ananth, J.; Parameswaran, S.

Treatment of Patients with Schizophrenia and Substance Abuse Disorders
pp. 2249-2261(13)
Authors: Tsuang, John; Fong, Timothy W.

Treatment Considerations in the Forensic Patient with Schizophrenia
pp. 2263-2267(5)
Authors: Stone, David C.; Niz, David O.

Cognitive Therapy for Schizophrenia: Treatment and Dissemination
pp. 2269-2275(7)
Authors: Marcinko, L.; Read, M.

Rehabilitation of Schizophrenic Patients
pp. 2277-2288(12)
Authors: Gunatilake, S.; Ananth, J.; Parameswaran, S.; Brown, S.; Silva, W.

< previous issue | all issues | next issue >

Marked list

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
^ Back to top
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page